Chambers Rebecca 4
4 · VERACYTE, INC. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Veracyte (VCYT) CFO Rebecca Chambers Sells Shares
What Happened
Rebecca Chambers, Veracyte's Chief Financial Officer, sold a total of 18,341 Veracyte (VCYT) shares in two open-market transactions on March 4, 2026, generating gross proceeds of approximately $662,869. The sales were: 4,400 shares at a weighted average price of $35.55 (proceeds $156,409) and 13,941 shares at a weighted average price of $36.33 (proceeds $506,460). These were sales (not purchases) and are often routine transactions.
Key Details
- Transaction dates: March 4, 2026 (reported on Form 4 filed March 6, 2026). No late filing flag indicated.
- Specific trades:
- 4,400 shares sold at weighted avg $35.55 (sale prices reported in range $35.00–$35.99). (F2)
- 13,941 shares sold at weighted avg $36.33 (sale prices reported in range $36.01–$36.55). (F3)
- Total shares sold: 18,341; total proceeds: ~$662,869.
- Shares owned after the transaction: Not specified in the provided filing.
- Notable footnote: Trades were made pursuant to a Rule 10b5-1 trading plan adopted by Ms. Chambers on August 21, 2025. (F1)
- Transaction code: S = Sale.
Context
A 10b5-1 plan means the sales may have been pre-scheduled and do not necessarily reflect the insider’s current view of the company. Sales by executives are common for liquidity or diversification reasons and should be interpreted differently than purchases, which often signal stronger insider conviction.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-03-04$35.55/sh−4,400$156,409→ 145,137 total - Sale
Common Stock
[F1][F3]2026-03-04$36.33/sh−13,941$506,460→ 131,196 total
Footnotes (3)
- [F1]The transaction on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.99. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $36.01 to $36.55. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.